These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20842046)

  • 21. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men.
    Dell'Omo G; Penno G; Giorgi D; Di Bello V; Mariani M; Pedrinelli R
    Am J Kidney Dis; 2002 Jul; 40(1):1-8. PubMed ID: 12087554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of microalbuminuria in the overall risk assessment of hypertensive patients].
    Leoncini G; Ratto E; Viazzi F; Pontremoli R
    G Ital Nefrol; 2007; 24(6):565-73. PubMed ID: 18278760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations.
    Jensen JS
    Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?
    de Jong PE; Gansevoort RT; Bakker SJ
    J Nephrol; 2007; 20(4):375-80. PubMed ID: 17879201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microalbuminuria--a valuable diagnostic parameter].
    Feldt-Rasmussen BF; Borch-Johnsen K; Deckert T; Jensen G; Jensen JS
    Ugeskr Laeger; 1993 Dec; 155(51):4149-54. PubMed ID: 8273236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microalbuminuria in non-insulin-dependent diabetes.
    Mogensen CE; Damsgaard EM; Frøland A; Nielsen S; de Fine Olivarius N; Schmitz A
    Clin Nephrol; 1992; 38 Suppl 1():S28-39. PubMed ID: 1295705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade.
    Menne J; Chatzikyrkou C; Haller H
    J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microalbuminuria--a risk factor for diabetic nephropathy and cardiovascular disease].
    Pontuch P
    Vnitr Lek; 2001 May; 47(5):307-10. PubMed ID: 11395874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria.
    Khosla N; Sarafidis PA; Bakris GL
    Clin Lab Med; 2006 Sep; 26(3):635-53, vi-vii. PubMed ID: 16938588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microalbuminuria in nondiabetic adults].
    Cirillo M; De Santo NG
    G Ital Nefrol; 2002; 19(3):273-7. PubMed ID: 12195394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.
    Bianchi S; Bigazzi R; Campese VM
    Am J Kidney Dis; 1999 Dec; 34(6):973-95. PubMed ID: 10585306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective.
    Lane JT
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F442-50. PubMed ID: 14761931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.
    Pedrinelli R; Dell'Omo G; Di Bello V; Pontremoli R; Mariani M
    J Hum Hypertens; 2002 Feb; 16(2):79-89. PubMed ID: 11850764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on microalbuminuria as a biomarker in renal and cardiovascular disease.
    Lambers Heerspink HJ; Brinkman JW; Bakker SJ; Gansevoort RT; de Zeeuw D
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):631-6. PubMed ID: 17053479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into the significance of microalbuminuria.
    MacIsaac RJ; Jerums G; Cooper ME
    Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):83-91. PubMed ID: 15090864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microalbuminuria: a useful marker of cardiovascular disease.
    Jarraya F; Lakhdar R; Kammoun K; Mahfoudh H; Drissa H; Kammoun S; Abid M; Hachicha J
    Iran J Kidney Dis; 2013 May; 7(3):178-86. PubMed ID: 23689147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.